- Home
- Health Tests
- Allergy
- Anaemia
- Andrology
- Autoimmune
- Biochemistry
- Blood Clotting
- Blood Group
- Bone Health
- Bowel Health
- Cancer Related
- Cardiac Health
- Coagulation
- Diabetes
- Fertility
- Genetics
- Haematology
- Health Checks
- Hormones
- Immunity
- Immunology
- Infections
- Inflamations
- Liver Health
- Men's Health
- Microbiology
- Molecular Biology
- Occupational Health
- Pathology
- Pregnancy
- Screen for Drug of Abuse
- Sexual Health
- Thyroid Health
- Vitamins
- Vitamins and Minerals
- Women's Health
- Genetic Tests
- MBMC
- MBMSK
- Aesthetic medicine
- Allergology
- Anatomical Pathology
- Andrology
- Bone Skin And Immune Diseases
- Cardiology
- Cardiovascular
- Custom Panel
- Cytohistology
- Dentistry
- Dermatology
- Endocrinology
- Forensic
- Gastroenterology
- Geriatrics
- Gynecology
- Hematology
- Hepatology
- Immunology
- Infectiology
- Infectivology
- Maxillofacial surgery
- Metabolic diseases
- Miscellaneous
- Neonatology
- Nephrology
- Neurology
- Nutrigenetics
- Nutrition
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pediatrics
- Pharmacogenetics
- Pneumology
- Prenatal
- Reproduction
- Rheumatology
- Senology
- Sports medicine
- Urology
- PrenatalSAFE® NIPT
- Cancer Screening
- Kits & Supplies
- Services
- About Us
- 0
- £0.000
- Sign in
Description
The diagnosis of adFEVR is based on a family history compatible with autosomal dominant inheritance and bilateral peripheral retinal avascularity, seen temporally, by indirect ophthalmoscope and scleral indentation, or by fundus fluorescein angiography.1) Molecular genetic testing should begin with sequence analysis of FZD4. 2) If a pathogenic variant is not identified, sequence analysis of LRP5 should be performed. 3) If a pathogenic variant is not identified, sequence analysis of TSPAN12 should be performed. 4) Because not all genes associated with adFEVR are known, failure to identify a pathogenic variant in FZD4, LRP5 or TSPAN12 does not rule out the diagnosis.
Additional information
Samples | EDTA |
---|---|
Method of testing | NGS |
Turnaround Time (TAT) | 30-40 days |
Number of Genes | 6 |
Genes / Chromosomes / SNPs | COL2A1, FZD4, LRP5, NDP, TSPAN12, VCAN |